Unusual metastatic patterns of urologic malignancies: a case series and literature review

Kursad Donmez^1,*, Enis Mert Yorulmaz², Enes Candemir², Serkan Ozcan², Osman Kose², Sacit Nuri Gorgel², Yigit Akin²
1 Department of Urology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, 35360, Turkey
2 Department of Urology, Izmir Katip Celebi University, Karabaglar, Izmir, 35620, Turkey
* Corresponding Author: Kursad Donmez. Email: email

Canadian Journal of Urology https://doi.org/10.32604/cju.2025.068294

Received 25 May 2025; Accepted 22 September 2025; Published online 04 December 2025

Abstract

Background: Urologic cancers typically metastasize to common organs, while spread to sites such as the heart, hand, cranial bones, penis, or tonsil is exceedingly rare. The clinical relevance and prognostic impact of these unusual metastases remain unclear. This case series highlights six exceptional cases, providing unique insights to support awareness and management. Case Description: We retrospectively analyzed six cases of patients diagnosed with urologic cancers who developed metastases at uncommon sites. Each case was evaluated based on clinical presentation, imaging findings, histopathological confirmation, treatment course, and outcomes. Relevant literature was reviewed to contextualize findings. Among the six cases, metastatic involvement was identified in atypical locations including the right atrium (testicular cancer), hand (bladder cancer), perineum and penis (sarcomatoid bladder cancer), cranial bones (prostate cancer), penis (rectal cancer), and tonsillar region (renal pelvis rhabdomyosarcoma). Timely imaging and histopathological confirmation guided personalized treatment strategies, primarily involving surgical interventions. Despite aggressive treatments, the prognosis remained poor in most cases, reflecting the aggressive nature of these metastases. Conclusion: Rare metastases from urologic malignancies, although uncommon, have significant implications on patient management. Early detection through advanced imaging and aggressive multimodal interventions are pivotal for improving outcomes. Awareness of such atypical metastatic patterns is essential for clinicians managing urologic cancers.